Work

Supplementary Figure 5 from Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Tolerability of combination therapy. MDA-MB-453 cells were injected into the mammary fat pads of cycling female nu/nu mice; n=6-7 mice per group. Sevi and/or Abem were administered daily. Mouse weights were measured throughout the experiment. Mean {plus minus} standard error of the mean.

DOI: 10.1158/1535-7163.22522309

Authors: Jessica L. Christenson, Kathleen I. O'Neill, Michelle M. Williams, Nicole S. Spoelstra, Kenneth L. Jones, G. Devon Trahan, Jordan Reese, Elaina T. Van Patten, Anthony Elias, Joel R. Eisner, Jennifer K. Richer

Institutions: University of Colorado Anschutz, University of Oklahoma Health Sciences Center, Innocrin Pharmaceuticals (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362488204

Cites: 55

Cited by:

Related to: 10